Related Experiment Videos
Morphometric diagnosis of bladder tumor.
1Department of Urology, First Affiliated Hospital, People's Republic of China.
Oncology
|January 1, 1991
Summary
A new morphometric grading system (M grading) for bladder tumors uses computer-assisted image analysis to assess nuclear features. Higher M grades correlate with lower survival, increased recurrence, and potential muscle invasion, aiding in prognosis.
Area of Science:
- Uropathology
- Oncology
- Medical image analysis
Background:
- Bladder cancer diagnosis and prognosis require objective methods.
- Morphometric analysis offers a quantitative approach to pathological assessment.
- Computer-assisted image analysis enhances the objectivity and reproducibility of morphometrics.
Purpose of the Study:
- To evaluate the efficacy of a novel morphometric grading system (M grading) for bladder transitional cell carcinoma.
- To correlate M grading with tumor behavior, including survival rates, recurrence, and muscle invasion.
- To establish a quantitative method for predicting bladder tumor prognosis.
Main Methods:
- Analysis of 100 bladder tumor cases using the Q-900 computer-assisted image analysis system.
- Quantitative assessment of nuclear area, axis ratio, and area ratio of tumor nuclei.
- Development and application of the morphometric grading system (M grading) based on nuclear parameters.
Main Results:
- The morphometric grading system (M grading) successfully stratified bladder tumors into 4 grades.
- Higher M grades were significantly associated with lower patient survival rates.
- Increased M grading correlated with higher tumor recurrence rates and a greater likelihood of muscle invasion.
Conclusions:
- The morphometric grading system (M grading) provides a quantitative and objective pathological diagnosis for bladder tumors.
- M grading effectively predicts the biological behavior and prognosis of bladder transitional cell carcinoma.
- This computer-assisted morphometric approach enhances diagnostic accuracy and prognostic capability in bladder cancer management.